Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction | Acute Coronary Syndromes | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.175.212.130. Please contact the publisher to request reinstatement.
1.
Nawar EW, Niska RW, Xu J. National Hospital Ambulatory Medical Care Survey: 2005 emergency department summary.  Adv Data. 2007;(386):1-3217703794PubMedGoogle Scholar
2.
Mehta SR, Granger CB, Boden WE,  et al; TIMACS Investigators.  Early versus delayed invasive intervention in acute coronary syndromes.  N Engl J Med. 2009;360(21):2165-217519458363PubMedGoogle ScholarCrossref
3.
Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.  J Am Coll Cardiol. 2000;36(3):959-96910987628PubMedGoogle ScholarCrossref
4.
Thygesen K, Alpert JS, White HD,  et al; Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction.  Universal definition of myocardial infarction.  Circulation. 2007;116(22):2634-265317951284PubMedGoogle ScholarCrossref
5.
Apple FS, Smith SW, Pearce LA, Ler R, Murakami MM. Use of the Centaur TnI-Ultra assay for detection of myocardial infarction and adverse events in patients presenting with symptoms suggestive of acute coronary syndrome.  Clin Chem. 2008;54(4):723-72818238833PubMedGoogle ScholarCrossref
6.
Reichlin T, Hochholzer W, Bassetti S,  et al.  Early diagnosis of myocardial infarction with sensitive cardiac troponin assays.  N Engl J Med. 2009;361(9):858-86719710484PubMedGoogle ScholarCrossref
7.
Keller T, Zeller T, Peetz D,  et al.  Sensitive troponin I assay in early diagnosis of acute myocardial infarction.  N Engl J Med. 2009;361(9):868-87719710485PubMedGoogle ScholarCrossref
8.
Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission.  Clin Chem. 2010;56(4):642-65020167697PubMedGoogle ScholarCrossref
9.
deFilippi CR, de Lemos JA, Christenson RH,  et al.  Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.  JAMA. 2010;304(22):2494-250221078811PubMedGoogle ScholarCrossref
10.
Saunders JT, Nambi V, de Lemos JA,  et al.  Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study.  Circulation. 2011;123(13):1367-137621422391PubMedGoogle ScholarCrossref
11.
Reichlin T, Irfan A, Twerenbold R,  et al.  Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction.  Circulation. 2011;124(2):136-14521709058PubMedGoogle ScholarCrossref
12.
Ambrose JA, Winters SL, Stern A,  et al.  Angiographic morphology and the pathogenesis of unstable angina pectoris.  J Am Coll Cardiol. 1985;5(3):609-6163973257PubMedGoogle ScholarCrossref
13.
Blankenberg S, Zeller T, Saarela O,  et al;  MORGAM Project.  Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project.  Circulation. 2010;121(22):2388-239720497981PubMedGoogle ScholarCrossref
14.
Wu A, Collinson P, Jaffe A, Morrow D. High-sensitivity cardiac troponin assays: what analytical and clinical issues need to be addressed before introduction into clinical practice? Interview by Fred S. Apple.  Clin Chem. 2010;56(6):886-89120378770PubMedGoogle ScholarCrossref
15.
DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach.  Biometrics. 1988;44(3):837-8453203132PubMedGoogle ScholarCrossref
16.
Pencina MJ, D’Agostino RB Sr, D’Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond.  Stat Med. 2008;27(2):157-17217569110PubMedGoogle ScholarCrossref
17.
Wu AHB, Jaffe AS, Apple FS,  et al; NACB Writing Group; NACB Committee.  National Academy of Clinical Biochemistry laboratory medicine practice guidelines: use of cardiac troponin and B-type natriuretic peptide or N-terminal proB-type natriuretic peptide for etiologies other than acute coronary syndromes and heart failure.  Clin Chem. 2007;53(12):2086-209617954494PubMedGoogle ScholarCrossref
18.
Apple FS, Pearce LA, Smith SW, Kaczmarek JM, Murakami MM. Role of monitoring changes in sensitive cardiac troponin I assay results for early diagnosis of myocardial infarction and prediction of risk of adverse events.  Clin Chem. 2009;55(5):930-93719299542PubMedGoogle ScholarCrossref
19.
Goldberg J, Iriarte B, Prostko J,  et al.  Short and long-term biological variability of troponin-i determined using the ARCHITECT STAT high sensitive troponin-I assay.  Clin Chem. 2011;57:A97Google Scholar
20.
Macrae AR, Kavsak PA, Lustig V,  et al.  Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies.  Clin Chem. 2006;52(5):812-81816556688PubMedGoogle ScholarCrossref
21.
Harris EK, Yasaka T. On the calculation of a “reference change” for comparing two consecutive measurements.  Clin Chem. 1983;29(1):25-306848276PubMedGoogle Scholar
22.
Wu AHB, Lu QA, Todd J, Moecks J, Wians F. Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice.  Clin Chem. 2009;55(1):52-5818988755PubMedGoogle ScholarCrossref
23.
Frankenstein L, Wu AHB, Hallermayer K, Wians FH Jr, Giannitsis E, Katus HA. Biological variation and reference change value of high-sensitivity troponin T in healthy individuals during short and intermediate follow-up periods.  Clin Chem. 2011;57(7):1068-107121519037PubMedGoogle ScholarCrossref
24.
Kavsak PA, Ko DT, Wang X, Macrae AR, Jaffe AS. 2007 Universal myocardial infarction definition change criteria for risk stratification by use of a high-sensitivity cardiac troponin I assay.  Clin Chem. 2010;56(3):487-48920075178PubMedGoogle ScholarCrossref
25.
Hochholzer W, Reichlin T, Stelzig C,  et al.  Impact of soluble fms-like tyrosine kinase-1 and placental growth factor serum levels for risk stratification and early diagnosis in patients with suspected acute myocardial infarction.  Eur Heart J. 2011;32(3):326-33521138939PubMedGoogle ScholarCrossref
26.
Keller T, Tzikas S, Zeller T,  et al.  Copeptin improves early diagnosis of acute myocardial infarction.  J Am Coll Cardiol. 2010;55(19):2096-210620447532PubMedGoogle ScholarCrossref
27.
Reichlin T, Hochholzer W, Stelzig C,  et al.  Incremental value of copeptin for rapid rule out of acute myocardial infarction.  J Am Coll Cardiol. 2009;54(1):60-6819555842PubMedGoogle ScholarCrossref
28.
Björk J, Forberg JL, Ohlsson M, Edenbrandt L, Ohlin H, Ekelund U. A simple statistical model for prediction of acute coronary syndrome in chest pain patients in the emergency department.  BMC Med Inform Decis Mak. 2006;6:2816824205PubMedGoogle ScholarCrossref
Original Contribution
December 28, 2011

Serial Changes in Highly Sensitive Troponin I Assay and Early Diagnosis of Myocardial Infarction

Author Affiliations

Author Affiliations: Department of General and Interventional Cardiology, University Heart Center Hamburg, Hamburg, Germany (Drs Keller, Zeller, Ojeda, Sinning, Baldus, and Blankenberg); Departments of Medicine II (Drs Tzikas, Wild, Genth-Zotz, Warnholtz, and Münzel and Mr Lillpopp) and Laboratory Medicine (Dr Lackner), University Medical Center, Johannes Gutenberg University Mainz, Mainz, Germany; Department of Laboratory Medicine, HELIOS Hospital Berlin-Buch, Berlin, Germany (Dr Peetz); Department of Internal Medicine, Federal Armed Hospital Koblenz, Koblenz, Germany (Dr Bickel); Department of Internal Medicine III, Cardiology, University Hospital Heidelberg, Heidelberg, Germany (Dr Giannitsis); and Department of Cardiology, Charité–Universitätsmedizin Berlin, Berlin, Germany (Dr Möckel).

JAMA. 2011;306(24):2684-2693. doi:10.1001/jama.2011.1896
Abstract

Context Introduction of highly sensitive troponin assays into clinical practice has substantially improved the evaluation of patients with chest pain.

Objective To evaluate the diagnostic performance of a highly sensitive troponin I (hsTnI) assay compared with a contemporary troponin I (cTnI) assay and their serial changes in the diagnosis of acute myocardial infarction (AMI).

Design, Setting, and Patients A total of 1818 patients with suspected acute coronary syndrome were consecutively enrolled at the chest pain units of the University Heart Center Hamburg, the University Medical Center Mainz, and the Federal Armed Forces Hospital Koblenz, all in Germany, from 2007 to 2008. Twelve biomarkers including hsTnI (level of detection, 3.4 pg/mL) and cTnI (level of detection, 10 pg/mL) were measured on admission and after 3 and 6 hours.

Main Outcome Measures Diagnostic performance for AMI of baseline and serial changes in hsTnI and cTnI results at 3 hours after admission to the emergency department.

Results Of the 1818 patients, 413 (22.7%) were diagnosed as having AMI. For discrimination of AMI, the area under the receiver operating characteristic (ROC) curve was 0.96 (95% CI, 0.95-0.97) for hsTnI on admission and 0.92 (95% CI, 0.90-0.94) for cTnI on admission. Both were superior to the other evaluated diagnostic biomarkers. The use of hsTnI at admission (with the diagnostic cutoff value at the 99th percentile of 30 pg/mL) had a sensitivity of 82.3% and a negative predictive value (for ruling out AMI) of 94.7%. The use of cTnI (with the diagnostic cutoff value at the 99th percentile of 32 pg/mL) at admission had a sensitivity of 79.4% and a negative predictive value of 94.0%. Using levels obtained at 3 hours after admission, the sensitivity was 98.2% and the negative predictive value was 99.4% for both hsTnI and cTnI assays. Combining the 99th percentile cutoff at admission with the serial change in troponin concentration within 3 hours, the positive predictive value (for ruling in AMI) for hsTnI increased from 75.1% at admission to 95.8% after 3 hours, and for cTnI increased from 80.9% at admission to 96.1% after 3 hours.

Conclusions Among patients with suspected acute coronary syndrome, hsTnI or cTnI determination 3 hours after admission may facilitate early rule-out of AMI. A serial change in hsTnI or cTnI levels from admission (using the 99th percentile diagnostic cutoff value) to 3 hours after admission may facilitate an early diagnosis of AMI.

×